HIGHLIGHTS
- who: u0423u0414u041a and collaborators from the Centro Hospitalar have published the research work: XEN gel stent in the management of glaucoma: preliminary results of a tertiary center, in the Journal: (JOURNAL)
SUMMARY
Eighteen eyes (52.9%) underwent XEN POAG: 20 eyes (58.8%) PEX: 7 eyes (20.6%) Secondary to steroid intravitreal implants: 5 eyes (14.7%) PCAG: 1 eye (2.9%) Juvenile Glaucoma: 1 eye (2.9%) Previous glaucoma surgeries 7 eyes (20.6%) Central corneal thickness (CCT) Follow-up (months) Baseline IOP (mmHg) P=0.104 Antiglaucoma topical medications P=0 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.